Lv1
50 积分 2021-09-23 加入
Icotinib in a lung adenocarcinoma patient with acquired EGFR 19del/C797S mutation-mediated resistance to osimertinib: a case report
5个月前
已完结
Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: AJR Expert Panel Narrative Review
1年前
已完结
EP07.05-02 NEOEAST: A Phase II Study of Ensartinib as Neoadjuvant Therapy for Stage II-IIIB ALK-rearranged Non-small Cell Lung Cancer
1年前
已完结
中医药治疗间变性淋巴瘤激酶阳性非小细胞肺癌患者恩沙替尼所致皮疹1例并文献复习
1年前
已完结
Phase II trial of icotinib in adult patients with neurofibromatosis type 2 and progressive vestibular schwannoma
1年前
已完结
HER2-Targeted Therapy Shows Promise across Tumor Types
1年前
已完结
A Bayesian network meta-analysis of ALK inhibitor treatments in patients with ALK-positive non-small cell lung cancer
1年前
已完结
Efficacy and safety of adjuvant EGFR TKI alone and in combination with chemotherapy for resected EGFR mutation-positive non-small cell lung cancer: A Bayesian network meta-analysis
1年前
已完结
阿帕替尼应用于晚期肺癌患者的效果观察
1年前
已完结
皖公网安备34019202002308
